<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: drug targets</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Got to go? Harvard scientists figure out how you know</title>
   	 <description>If you have an overactive bladder or incontinence, help could be on the way. A new research report published online in the FASEB Journal, shows that the epithelium, a thin layer of cells which line the surface of the bladder, is able to sense how full the bladder is through the action of a family of proteins called integrins. As the bladder becomes full, the cells in the epithelium stretch and become thinner, which activates the integrins to send that information to nerves and other cells in the bladder. As a result of this new knowledge, researchers may one day be able to design drugs that target this mechanism to treat conditions like incontinence and overactive bladder, both of which are common, serious, problems affecting millions of people.</description>
     <link>http://medicalxpress.com/news/2013-02-harvard-scientists-figure.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 08 Feb 2013 17:21:22 EST</pubDate>
	 <guid isPermaLink="false">news279566477</guid>
	 
</item>
<item>
     <title>Green tea and red wine extracts interrupt Alzheimer's disease pathway in cells</title>
   	 <description>Natural chemicals found in green tea and red wine may disrupt a key step of the Alzheimer's disease pathway, according to new research from the University of Leeds.</description>
     <link>http://medicalxpress.com/news/2013-02-green-tea-red-wine-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 05 Feb 2013 18:00:01 EST</pubDate>
	 <guid isPermaLink="false">news279305737</guid>
	 
</item>
<item>
     <title>Could traditional Chinese medicine hold an answer to the obesity problem?</title>
   	 <description>Obesity might be a very modern problem, but a team of scientists from Taiwan and China is turning to the age-old principles of traditional Chinese medicine (TCM) to help fight it.  Breaking research published in the Journal of Biomolecular Structure and Dynamics indicates a possible new direction for the treatment of metabolic syndrome.</description>
     <link>http://medicalxpress.com/news/2013-01-traditional-chinese-medicine-obesity-problem.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 31 Jan 2013 07:13:51 EST</pubDate>
	 <guid isPermaLink="false">news278838824</guid>
	 
</item>
<item>
     <title>SNPs associated with breast cancer risk alter binding affinity for pioneer factor FOXA1</title>
   	 <description>Dartmouth scientists showed that more than half of all the SNPs associated with breast cancer risk are located in distant regions and bound by FOXA1, a protein required for estrogen receptor-α (ER) function according to a paper published in the journal Nature Genetics in November.</description>
     <link>http://medicalxpress.com/news/2013-01-snps-breast-cancer-affinity-factor.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 23 Jan 2013 16:17:02 EST</pubDate>
	 <guid isPermaLink="false">news278180216</guid>
	 
</item>
<item>
     <title>First special edition updating progress on efforts to map human proteins</title>
   	 <description>Almost 10 years after completion of the Human Genome Project in 2003, scientists are making progress toward the next major goal in applying the genetic information in that &quot;Book of Life&quot; in medicine, leaders of an international research effort are reporting. A package of the latest updates on the goals, organization and achievements of the Chromosome-Centric Human Proteome Project (C-HPP) appear in a special issue of ACS' Journal of Proteome Research.</description>
     <link>http://medicalxpress.com/news/2013-01-special-efforts-human-proteins.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 23 Jan 2013 10:30:40 EST</pubDate>
	 <guid isPermaLink="false">news278159433</guid>
	 
</item>
<item>
     <title>Researchers foresee new therapies and diagnostics for deadly fibrotic diseases</title>
   	 <description>A team of scientists has developed a playbook for ending the devastating impact of fibrotic diseases of the liver, lung, kidney, and other organs, which are responsible for as many as 45 percent of all deaths in the industrialized world. Despite the prevalence of these illnesses, which are caused by buildup of scar tissue, there are no approved antifibrotic drugs on the market in the U.S. A top fibrosis expert from the Icahn School of Medicine at Mount Sinai and three other institutions have described drug targets and compounds they hope will prove broadly effective in an article, &quot;Therapy for Fibrotic Diseases: Nearing the Starting Line,&quot; appearing in the January 9 issue of Science Translational Medicine.</description>
     <link>http://medicalxpress.com/news/2013-01-therapies-diagnostics-deadly-fibrotic-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 09 Jan 2013 14:00:04 EST</pubDate>
	 <guid isPermaLink="false">news276958730</guid>
	 
</item>
<item>
     <title>Fusion gene contributes to glioblastoma progression</title>
   	 <description>Fusion genes are common chromosomal aberrations in many cancers, and can be used as prognostic markers and drug targets in clinical practice.</description>
     <link>http://medicalxpress.com/news/2013-01-fusion-gene-contributes-glioblastoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 09 Jan 2013 13:07:49 EST</pubDate>
	 <guid isPermaLink="false">news276959258</guid>
	 
</item>
<item>
     <title>Study: Most-used diabetes drug works in different way than previously thought</title>
   	 <description>A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, found that the diabetes drug metformin works in a different way than previously understood. Their research in mice found that metformin suppresses the liver hormone glucagon's ability to generate an important signaling molecule, pointing to new drug targets. The findings were published online this week in Nature.</description>
     <link>http://medicalxpress.com/news/2013-01-most-used-diabetes-drug-previously-thought.html</link>
	 <category>Diabetes</category>
	 <pubDate>Sun, 06 Jan 2013 13:00:31 EST</pubDate>
	 <guid isPermaLink="false">news276685322</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/4tfdhllk.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists use 'virtual experiments' to uncover missing cancer targets</title>
   	 <description>(Medical Xpress)—Scientists have identified 46 previously overlooked but potentially 'druggable' cancer targets, using a powerful new online approach that allows researchers to carry out 'virtual experiments' to quickly prioritise which are the best targets for drug discovery. The findings are published in the journal Nature Reviews Drug Discovery today.</description>
     <link>http://medicalxpress.com/news/2013-01-scientists-virtual-uncover-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 02 Jan 2013 08:53:14 EST</pubDate>
	 <guid isPermaLink="false">news276339123</guid>
	 
</item>
<item>
     <title>World-first tissue study could re-shape future of advanced prostate cancer treatment</title>
   	 <description>The first-ever comprehensive study of prostate cancer tissue has revealed a completely new gene network driving the disease in patients who have stopped responding to standard hormone treatment, according to Cancer Research UK research published today in Cancer Cell.</description>
     <link>http://medicalxpress.com/news/2012-12-world-first-tissue-re-shape-future-advanced.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 21 Dec 2012 06:39:37 EST</pubDate>
	 <guid isPermaLink="false">news275294369</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/worldfirstti.jpg" width="90" height="90" />
</item>
<item>
     <title>Study finds new targets for drugs to defeat aggressive brain tumor</title>
   	 <description>University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.</description>
     <link>http://medicalxpress.com/news/2012-12-drugs-defeat-aggressive-brain-tumor.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 14 Dec 2012 10:26:52 EST</pubDate>
	 <guid isPermaLink="false">news274702934</guid>
	 
</item>
<item>
     <title>Cancer stem cells isolated from kidney tumors</title>
   	 <description>Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic approach that one day might be used to treat some of the more aggressive types of this disease. The results are published online in EMBO Molecular Medicine.</description>
     <link>http://medicalxpress.com/news/2012-12-cancer-stem-cells-isolated-kidney.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Dec 2012 08:41:44 EST</pubDate>
	 <guid isPermaLink="false">news274610497</guid>
	 
</item>
<item>
     <title>TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients</title>
   	 <description>Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research.</description>
     <link>http://medicalxpress.com/news/2012-12-tgen-us-oncology-treatment-metastatic-triple-negative.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 06 Dec 2012 15:19:37 EST</pubDate>
	 <guid isPermaLink="false">news274029561</guid>
	 
</item>
<item>
     <title>Genome-scale study identifies hundreds of potential drug targets for Huntington's disease</title>
   	 <description>Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify hundreds of &quot;druggable&quot; molecular targets linked to the toxicity associated with the devastating, ultimately fatal disease. The results from this unprecedented genome-scale screen in a human cell model of HD are published in the November 29, 2012 edition of PLOS Genetics. The work was is a collaboration between Buck Institute faculty members Robert E. Hughes, Ph.D., Sean Mooney, Ph.D., Lisa Ellerby, Ph.D. and Juan Botas, Ph.D. at the Baylor College of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-11-genome-scale-hundreds-potential-drug-huntington.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 29 Nov 2012 17:32:16 EST</pubDate>
	 <guid isPermaLink="false">news273432726</guid>
	 
</item>
<item>
     <title>Scientists identify progenitor cells, potential new 'roots' of breast cancer</title>
   	 <description>Scientists have discovered new types of early cells in mammary glands, uncovering clues to the origins of different breast cancers - and potential new drug targets, according to findings published in Breast Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-10-scientists-progenitor-cells-potential-roots.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Oct 2012 10:50:12 EST</pubDate>
	 <guid isPermaLink="false">news270725994</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/33-scientistsdi.jpg" width="90" height="90" />
</item>
<item>
     <title>Some MS patients experience 'natural' improvements in disability</title>
   	 <description>(Medical Xpress)—Multiple sclerosis (MS) patients sometimes experience &quot;natural&quot; improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.</description>
     <link>http://medicalxpress.com/news/2012-10-ms-patients-natural-disability.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 18 Oct 2012 07:41:15 EST</pubDate>
	 <guid isPermaLink="false">news269764866</guid>
	 
</item>
<item>
     <title>Study identifies adhesion molecules key to cancer's spread through the body</title>
   	 <description>Although tumor metastasis causes about 90 percent of cancer deaths, the exact mechanism that allows cancer cells to spread from one part of the body to another is not well understood. One key question is how tumor cells detach from the structural elements that normally hold tissues in place, then reattach themselves in a new site.</description>
     <link>http://medicalxpress.com/news/2012-10-adhesion-molecules-key-cancer-body.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 09 Oct 2012 15:38:59 EST</pubDate>
	 <guid isPermaLink="false">news269015911</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/howcancercel.jpg" width="90" height="90" />
</item>
<item>
     <title>Mathematical modelling to tackle metabolic diseases</title>
   	 <description>Predictive mathematical models of signalling pathways are powerful biological tools that could be used for drug development. Using a similar approach, European scientists developed a computational model for answering research questions regarding the AMP-activated protein kinase pathway.</description>
     <link>http://medicalxpress.com/news/2012-08-mathematical-tackle-metabolic-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 30 Aug 2012 09:25:34 EST</pubDate>
	 <guid isPermaLink="false">news265537529</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/2-mathematical.jpg" width="90" height="90" />
</item>
<item>
     <title>New nanoparticles that shut off cancer genes shrink tumors in mice</title>
   	 <description>By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion.</description>
     <link>http://medicalxpress.com/news/2012-08-nanoparticles-cancer-genes-tumors-mice.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 Aug 2012 14:00:06 EST</pubDate>
	 <guid isPermaLink="false">news264252262</guid>
	 
</item>
<item>
     <title>Scientists use worms to unearth cancer drug targets</title>
   	 <description>Through novel experiments involving small nematode worms, scientists from Wyoming have discovered several genes that may be potential targets for drug development in the ongoing war against cancer. Specifically, researchers hypothesize that inhibiting these genes could reverse certain key traits associated with cancer cells. This discovery is published in the August 2012 issue of the Genetics Society of America's journal GENETICS.</description>
     <link>http://medicalxpress.com/news/2012-08-scientists-worms-unearth-cancer-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 11:28:05 EST</pubDate>
	 <guid isPermaLink="false">news263730476</guid>
	 
</item>
<item>
     <title>New method to find novel connections from gene to gene, drug to drug and between scientists</title>
   	 <description>Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.</description>
     <link>http://medicalxpress.com/news/2012-07-method-gene-drug-scientists.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 24 Jul 2012 17:05:15 EST</pubDate>
	 <guid isPermaLink="false">news262368300</guid>
	 
</item>
<item>
     <title>Lungs respond to hospital ventilator as if it were an infection</title>
   	 <description>When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immune response that can lead to excessive inflammation, new research suggests.</description>
     <link>http://medicalxpress.com/news/2012-07-lungs-hospital-ventilator-infection.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 18 Jul 2012 17:00:47 EST</pubDate>
	 <guid isPermaLink="false">news261849639</guid>
	 
</item>
<item>
     <title>Hulk smash? Maybe not anymore: scientists block excess aggression in mice</title>
   	 <description>Pathological rage can be blocked in mice, researchers have found, suggesting potential new treatments for severe aggression, a widespread trait characterized by sudden violence, explosive outbursts and hostile overreactions to stress.</description>
     <link>http://medicalxpress.com/news/2012-06-hulk-anymore-scientists-block-excess.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 19 Jun 2012 17:00:16 EST</pubDate>
	 <guid isPermaLink="false">news259341016</guid>
	 
</item>
<item>
     <title>Improving obesity-induced insulin sensitivity</title>
   	 <description>In recent years, a growing body of evidence has linked inflammation to the development of insulin resistance. In insulin resistance, the hormone insulin is less effective in promoting glucose uptake from the bloodstream into other tissues. Obesity is a major factor that contributes to insulin resistance, which can eventually lead to type 2 diabetes. Previous studies have shown that proinflammatory molecules found in fat tissue decreases sensitivity of tissues to insulin.</description>
     <link>http://medicalxpress.com/news/2012-06-obesity-induced-insulin-sensitivity.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Fri, 01 Jun 2012 13:05:49 EST</pubDate>
	 <guid isPermaLink="false">news257774686</guid>
	 
</item>
<item>
     <title>The right combination: Overcoming drug resistance in cancer</title>
   	 <description>Overactive epidermal growth factor receptor (EGFR) signaling has been linked to the development of cancer. Several drug therapies have been developed to treat these EGFR-associated cancers; however, many patients have developed resistance to these drugs and are therefore no longer responsive to drug treatment. </description>
     <link>http://medicalxpress.com/news/2012-06-combination-drug-resistance-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 01 Jun 2012 13:01:11 EST</pubDate>
	 <guid isPermaLink="false">news257774460</guid>
	 
</item>
<item>
     <title>Early biomarker for pancreatic cancer identified</title>
   	 <description>Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper will be published May 15 in Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-05-early-biomarker-pancreatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 15 May 2012 00:20:01 EST</pubDate>
	 <guid isPermaLink="false">news256233809</guid>
	 
</item>
<item>
     <title>Scientists find new breast cancer genes, rewrite rulebook</title>
   	 <description>Scientists at the BC Cancer Agency and University of British Columbia have identified new breast cancer genes that could change the way the disease is diagnosed and form the basis of next-generation treatments.</description>
     <link>http://medicalxpress.com/news/2012-04-scientists-breast-cancer-genes-rewrite.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Apr 2012 13:00:15 EST</pubDate>
	 <guid isPermaLink="false">news253972596</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/9-scientistsfi.jpg" width="90" height="90" />
</item>
<item>
     <title>Pancreatic cancer clinical trial results released</title>
   	 <description>The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.</description>
     <link>http://medicalxpress.com/news/2012-04-pancreatic-cancer-clinical-trial-results.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 09:51:24 EST</pubDate>
	 <guid isPermaLink="false">news252665467</guid>
	 
</item>
<item>
     <title>Memory formation triggered by stem cell development</title>
   	 <description>Researchers at the RIKEN-MIT Center for Neural Circuit Genetics have discovered an answer to the long-standing mystery of how brain cells can both remember new memories while also maintaining older ones.</description>
     <link>http://medicalxpress.com/news/2012-02-memory-formation-triggered-stem-cell.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 23 Feb 2012 12:56:36 EST</pubDate>
	 <guid isPermaLink="false">news249224191</guid>
	 
</item>
<item>
     <title>Genetic risks for type 2 diabetes span multiple ethnicities</title>
   	 <description>A recent large and comprehensive analysis of 50,000 genetic variants across 2,000 genes linked to cardiovascular and metabolic function has identified four genes associated with type 2 diabetes (T2D) and six independent disease-associated variants at previously known loci. The findings, which provide valuable insight into the genetic risk for T2D across multiple ethnicities, add to the growing list of genetic variants that affect the risk of developing T2D and could pave the way for identification of valuable drug targets. The research will be published by Cell Press on February 9th in The American Journal of Human Genetics, the official journal of the American Society of Human Genetics.</description>
     <link>http://medicalxpress.com/news/2012-02-genetic-diabetes-span-multiple-ethnicities.html</link>
	 <category>Diabetes</category>
	 <pubDate>Thu, 09 Feb 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news248007170</guid>
	 
</item>


</channel>
</rss>
